Strategic Partnership Sinclair Research is now part of Altasciences, expanding capabilities to full preclinical and early-phase clinical development. This positions the company to offer integrated services from IND-enabling studies through early clinical testing, presenting a bundled sales proposition to biopharma sponsors seeking streamlined timelines.

Specialized Expertise Leading miniature swine models and extensive diabetes, dermal, otic, and animal health research expertise create a differentiator for sponsors with specialized niche programs or regulatory-compliant GLP, VICH, and SEND reporting needs that require high-quality, recognized CRO capabilities.

Global Scale Opportunity Altasciences operates across nine North American locations with a long track record, enabling regional and global sponsors to access coordinated preclinical and early-phase services, potential faster start-up timelines, and site-specific capacity planning.

Technology Enablement Adoption of diverse tech stack and partnerships with industry players (such as VoxCell BioInnovation for 3D tissue models and Certara for model-informed drug development) signals opportunities to position clients near advanced modeling, data management, and predictive analytics for better decision-making.

Recognition & Growth Awards in CRO leadership and sustainability partnerships (EcoVadis) indicate market credibility and growing differentiation, which can be leveraged to engage sponsors prioritizing quality, ESG-aligned vendors, and proven performance in small-molecule and specialty programs.